Compare StocksARES vs PFE

Ares Management Corporation (ARES) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-09-17, ARES is overvalued at $127, with a DCF intrinsic value of $71 and a margin of safety of -79%. PFE is overvalued at $28, with an intrinsic value of $22 and a margin of safety of -23%. Of the two, PFE has the wider margin of safety.

ARES
Ares Management Corporation
$127.19
VS
PFE
Pfizer Inc.
$27.64

Rewards

ARES
  • Trailing P/E of 58.1x is 25% below the historical average of 77.2x — potentially undervalued relative to its own history.
  • PEG ratio of 0.92 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.
PFE
  • Gross margin of 74.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Insiders have bought $3.0M worth of stock in the past 3 months — significant skin in the game.

Risks

ARES
  • Share count has increased by 25% over the past 4 years, diluting existing shareholders.
  • FCF yield of 7.6% suggests reasonable valuation assuming continued moderate growth.
  • High leverage (1.51x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • FCF yield of 7.9% suggests reasonable valuation assuming continued moderate growth.
  • PEG ratio of 12.68 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
ARES
PFE
Valuation
$3.19B
Free Cash Flow
$12.49B
7.57%
FCF Yield
7.92%
58.08
Trailing P/E
36.38
17.68
Forward P/E
9.54
Quality & Moat
3.90%
ROIC
9.42%
14.94%
ROE
5.01%
37.41%
Gross Margin
74.72%
0.92
PEG Ratio
12.68
Balance Sheet Safety
1.51
Net Debt / Equity
0.61
N/A
Interest Coverage
N/A
9.10
Net Debt / EBITDA
2.04
4.35%
Dividend Yield
6.26%
ARES: 2Ties: 2PFE: 8
ARESPFE

Historical Fundamentals

Learn more →
ARES

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ARES
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-2.63B
Δ Market Cap
+$23.73B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ARES
79.4% Overvalued
Price is 79.4% above estimated fair value
Current Price: $127.19
Fair Value: $70.91
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
23.2% Overvalued
Price is 23.2% above estimated fair value
Current Price: $27.64
Fair Value: $22.43
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ARES

What growth rate is the market pricing in at $127?

+26.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +5.7%

The market implies +26.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +5.7%, reflecting heavy growth investment.

PFE

What growth rate is the market pricing in at $28?

+6.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +5.3%

The market implies +6.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +5.3%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ARES
47/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ARES
-2.63
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ARES
Insiders 11.2%Institutions 93.5%
No. of Institutional Holders1,136
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.1%Retail & Other 30.8%
No. of Institutional Holders3,645
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ARES
0
Buys (3M)
2
Buys (12M)
Total value (12M): $1.33M
OLIAN JUDY D.
Director
$59,726
@ $124.43 · 2026-02-20
BHUTANI ASHISH
Director
$1.27M
@ $126.61 · 2026-02-06
BHUTANI ASHISH
Director
$1.41M
@ $141.33 · 2025-03-11
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
3
Buys (3M)
3
Buys (12M)
Total value (12M): $2.96M
BOURLA ALBERT
Chief Executive Officer
$1.00M
@ $26.34 · 2026-08-12
BLAYLOCK RONALD E
Director
$998,821
@ $25.46 · 2026-08-05
BUCKLEY MORTIMER J.
Director
$960,369
@ $25.52 · 2026-08-05
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ARES
0
Sells (3M)
3
Sells (12M)
Total value (12M): $4.10M
SAGATI AGHILI NASEEM
General Counsel
$529,032
@ $134.92 · 2026-02-04
SAGATI AGHILI NASEEM
General Counsel
$299,239
@ $161.84 · 2026-01-22
SAGATI AGHILI NASEEM
General Counsel
$3.28M
@ $155.97 · 2025-10-01
SAGATI AGHILI NASEEM
General Counsel
$3.75M
@ $178.40 · 2025-09-10
AROUGHETI MICHAEL J
Chief Executive Officer
$16.98M
@ $153.17 · 2025-03-24
DEVEER ROBERT KIPP III
President
$15.00M
@ $190.02 · 2025-02-06
BERRY RYAN
Officer
$2.62M
@ $180.16 · 2024-12-11
DEVEER ROBERT KIPP III
Officer and Director
$53.15M
@ $177.16 · 2024-12-10
BERRY RYAN
Officer
$980,502
@ $180.14 · 2024-12-09
BERRY RYAN
Officer
$292,425
@ $175.00 · 2024-11-11
BERRY RYAN
Officer
$3.21M
@ $175.18 · 2024-11-06
BERRY RYAN
Officer
$6.72M
@ $167.99 · 2024-10-17
BERRY RYAN
Officer
$3.20M
@ $160.07 · 2024-10-04
BERRY RYAN
Officer
$7.66M
@ $153.30 · 2024-09-19
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
2
Sells (12M)
Total value (12M): $134,661
DAMICO JENNIFER B.
Officer
$83,261
@ $25.40 · 2026-08-05
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ARES
FearGreed
😨Fear(29/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(60/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ARES
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (29)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (60)
View ARES Full AnalysisView PFE Full Analysis

Frequently Asked Questions: ARES vs PFE

Is Ares Management Corporation or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, PFE trades at a -23.2% margin of safety (intrinsic value $22 vs. price $28), compared to ARES's -79.4% margin of safety (intrinsic $71 vs. $127).

Which stock has a wider economic moat, Ares Management Corporation or Pfizer Inc.?

ARES scores 47/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Ares Management Corporation in financial distress?

ARES's Altman Z-Score of 1.4 places it in the Distress zone, signaling elevated bankruptcy risk. PFE scores 2.1 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Ares Management Corporation or Pfizer Inc.?

Pfizer Inc. (PFE) generates a 7.9% free cash flow yield, compared to Ares Management Corporation's 7.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Ares Management Corporation or Pfizer Inc.?

PFE earns 9.4% ROIC versus ARES's 3.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Ares Management Corporation's or Pfizer Inc.'s?

ARES's dividend earns a safety score of 54/100 (Borderline), compared to PFE's 24/100 (Unsafe). ARES has raised its dividend for 3 consecutive years.

ARES vs PFE: Which Is the Better Buy in 2026? | SafetyMargin.io